Research use only. Read more

Anti-inflammatory

GLOW (50/10/10)

High-strength variant of the GLOW skin and connective-tissue blend (GHK-Cu + BPC-157 + TB-500 at double mass).

Quick facts

Molecular weight

340 Da

Half-life

1 h

Frequency

daily

Admins / wk

7

Routes

SubQ

Typical dose

1.00 mg–3.00 mg

Mechanism & positioning

High-strength variant of the GLOW skin and connective-tissue blend (GHK-Cu + BPC-157 + TB-500 at double mass).

Researched for: skin regeneration, connective-tissue repair.

Blend composition

ComponentMass in vial% of blend
GHK-Cu50 mg71.4%Profile
BPC-15710 mg14.3%Profile
TB-50010 mg14.3%Profile

Reconstitution defaults

Default vial

70 mg

BAC water

3 mL

Concentration

23333 mcg/mL

Doses per vial

~70

Calculate with this peptide

Related peptides in the Anti-inflammatory class

Frequently asked questions about GLOW (50/10/10)

What is the typical research dose range for GLOW (50/10/10)?
GLOW (50/10/10) is most commonly investigated at 1.00 mg–3.00 mg per administration, daily. Note: per GHK-Cu component. These values reflect documented research-stage protocols and are not medical recommendations.
What is the half-life of GLOW (50/10/10)?
GLOW (50/10/10) has an approximate plasma half-life of 1 hours. Practical steady state is reached after roughly five half-lives — about 0 days under continuous administration.
How is GLOW (50/10/10) administered in research protocols?
Published research uses subq administration. Typical reconstitution is 70 mg vial in 3 mL of bacteriostatic water, producing a concentration of 23333 mcg/mL.
What vial sizes are commonly available for GLOW (50/10/10)?
Common stocked vial sizes are 70 mg. The 70 mg vial is the most-used default in published protocols.